Optimizing Aptamer Activity for Gene Therapy Applications Using Expression Cassette SELEX
Open Access
- 1 July 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 6 (1) , 30-34
- https://doi.org/10.1006/mthe.2002.0624
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Nuclease-resistant synthetic ribozymes: developing a new class of therapeuticsJournal of Clinical Investigation, 2000
- Developing aptamers into therapeuticsJournal of Clinical Investigation, 2000
- Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.Journal of Clinical Investigation, 1998
- Expression of small, therapeutic RNAs in human cell nucleiGene Therapy, 1997
- Cancer Cell CyclesScience, 1996
- In vitro selection of aptamers: the dearth of pure reasonCurrent Opinion in Structural Biology, 1996
- New Ways of Making Drugs. RNA and Peptides by Selection and Molecular DesignAnnals of the New York Academy of Sciences, 1993
- Expression of transcription factor E2F1 induces quiescent cells to enter S phaseNature, 1993
- Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replicationCell, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990